DMPA and HIV: What Advocates Need to Know

This tool summarizes important takeaways for advocates from new guidance released by the WHO in 2017 on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV. Incorporate the information in this tool into an advocacy strategy development and messaging, especially for countries with high rates of HIV among women and adolescent girls.